Common Contracts

5 similar Separation Agreement contracts by Diffusion Pharmaceuticals Inc.

Re: Separation from Employment and General Release
Separation Agreement • May 19th, 2023 • Diffusion Pharmaceuticals Inc. • Pharmaceutical preparations

This letter agreement and general release (this “Agreement”) sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, “Diffusion” or the “Company”) effective May 15, 2023 (the “Separation Date”). References in this Agreement to “you” and “your” refer to Mr. William Hornung.

AutoNDA by SimpleDocs
Re: Separation from Employment and General Release
Separation Agreement • May 19th, 2023 • Diffusion Pharmaceuticals Inc. • Pharmaceutical preparations

This letter agreement and general release (this “Agreement”) sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, “Diffusion” or the “Company”) effective May 15, 2023 (the “Separation Date”). References in this Agreement to “you” and “your” refer to Mr. William Hornung.

Re: Separation from Employment and General Release Dear Raven,
Separation Agreement • March 24th, 2023 • Diffusion Pharmaceuticals Inc. • Pharmaceutical preparations

This letter agreement and general release (this “Agreement”) sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, “Diffusion” or the “Company”) effective March 1, 2023 (the “Separation Date”). References in this Agreement to “you” and “your” refer to Ms. Raven Jaeger, M.S.

Re: Separation from Employment and General Release Dear Chris,
Separation Agreement • March 24th, 2023 • Diffusion Pharmaceuticals Inc. • Pharmaceutical preparations

This letter agreement and general release (this “Agreement”) sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, “Diffusion” or the “Company”) effective March 1, 2023 (the “Separation Date”). References in this Agreement to “you” and “your” refer to Dr. Christopher D. Galloway, M.D.

Re: Separation from Employment and General Release
Separation Agreement • February 16th, 2023 • Diffusion Pharmaceuticals Inc. • Pharmaceutical preparations

This letter agreement and general release (this “Agreement”) sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, “Diffusion” or the “Company”) effective March 1, 2023 (the “Separation Date”). References in this Agreement to “you” and “your” refer to [_____].

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!